ABUS

SEC source: 0001447028-26-000061 · wk-form4_1791403925.xml · nonDerivative · entry 1

Beardsley Robert A · CIK 0001310845 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,328

F1 · shares: Represents common shares tendered to the Issuer pursuant to the Issuer's tender offer. The Issuer took up and accepted the common shares for payment on October 1, 2026.

SEC source: 0001447028-26-000060 · wk-form4_1791403899.xml · nonDerivative · entry 1

Nguyen Tuan · CIK 0002063445 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 111,882

F1 · shares: Represents common shares tendered to the Issuer pursuant to the Issuer's tender offer. The Issuer took up and accepted the common shares for payment on October 1, 2026.

SEC source: 0001447028-26-000059 · wk-form4_1791403791.xml · nonDerivative · entry 1

Sawhney Roger · CIK 0001858748 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,683

F1 · shares: Represents common shares tendered to the Issuer pursuant to the Issuer's tender offer. The Issuer took up and accepted the common shares for payment on October 1, 2026.

SEC source: 0001447028-26-000058 · wk-form4_1791403746.xml · nonDerivative · entry 1

Androski Lindsay · CIK 0001936604 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,682

F1 · shares: Represents common shares tendered to the Issuer pursuant to the Issuer's tender offer. The Issuer took up and accepted the common shares for payment on October 1, 2026.

SEC source: 0001140361-26-038692 · form4.xml · nonDerivative · entry 1

Roivant Sciences Ltd. · CIK 0001635088 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,880,079

SEC source: 0001447028-26-000053 · wk-form4_1790209942.xml · derivative · entry 5

Androski Lindsay · CIK 0001936604 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,244

Underlying: Common Shares · 10,456 shares

Expires 2036-02-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option, representing a right to purchase a total of 71,700 shares, vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the February 2, 2026 grant date, subject to the Reporting Person's continuous service as of each vesting date.

SEC source: 0001447028-26-000053 · wk-form4_1790209942.xml · derivative · entry 4

Androski Lindsay · CIK 0001936604 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 194,014

Underlying: Common Shares · 116,408 shares

Expires 2035-03-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option, representing a right to purchase a total of 310,422 shares, vests over a four-year period, with 25% of the total shares subject to the option vesting on the 1st anniversary of the March 18, 2025 grant date and the remaining 75% vesting over the subsequent three-year period in substantially equal monthly installments at a rate of 1/48th of the total shares subject to the option each month, subject to the Reporting Person's continuous service as of each vesting date.

SEC source: 0001447028-26-000053 · wk-form4_1790209942.xml · nonDerivative · entry 3

Androski Lindsay · CIK 0001936604 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,337

F1 · kind: The Reporting Person exercised options on September 18, 2026. The Issuer withheld an aggregate of 82,527 shares otherwise issuable upon the exercises to satisfy the aggregate exercise prices.

SEC source: 0001447028-26-000053 · wk-form4_1790209942.xml · nonDerivative · entry 2

Androski Lindsay · CIK 0001936604 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 154,864

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001447028-26-000053 · wk-form4_1790209942.xml · nonDerivative · entry 1

Androski Lindsay · CIK 0001936604 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 144,408

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001447028-26-000052 · wk-form4_1790209910.xml · derivative · entry 5

Nguyen Tuan · CIK 0002063445 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 160,925

Underlying: Common Shares · 27,475 shares

Expires 2036-02-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option, representing a right to purchase a total of 188,400 shares, vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the February 2, 2026 grant date, subject to the Reporting Person's continuous service as of each vesting date.

SEC source: 0001447028-26-000052 · wk-form4_1790209910.xml · derivative · entry 4

Nguyen Tuan · CIK 0002063445 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 484,375

Underlying: Common Shares · 265,625 shares

Expires 2035-03-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option, representing a right to purchase a total of 750,000 shares, vests over a four-year period, with 25% of the total shares subject to the option vesting on the 1st anniversary of the March 31, 2025 grant date and the remaining 75% vesting over the subsequent three-year period in substantially equal monthly installments at a rate of 1/48th of the total shares subject to the option each month, subject to the Reporting Person's continuous service as of each vesting date.

SEC source: 0001447028-26-000052 · wk-form4_1790209910.xml · nonDerivative · entry 3

Nguyen Tuan · CIK 0002063445 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 159,963

F1 · kind: The Reporting Person exercised options on September 18, 2026. The Issuer withheld an aggregate of 206,637 shares otherwise issuable upon the exercises to satisfy the aggregate exercise prices.

SEC source: 0001447028-26-000052 · wk-form4_1790209910.xml · nonDerivative · entry 2

Nguyen Tuan · CIK 0002063445 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 366,600

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001447028-26-000052 · wk-form4_1790209910.xml · nonDerivative · entry 1

Nguyen Tuan · CIK 0002063445 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 339,125

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001447028-26-000051 · wk-form4_1790209875.xml · derivative · entry 5

Sawhney Roger · CIK 0001858748 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 78,800 shares

Expires 2036-06-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option, representing a right to purchase a total of 78,800 shares, was fully vested and exercisable as of the June 8, 2026 grant date.

SEC source: 0001447028-26-000051 · wk-form4_1790209875.xml · derivative · entry 4

Sawhney Roger · CIK 0001858748 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,067

Underlying: Common Shares · 52,533 shares

Expires 2035-08-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option, representing a right to purchase a total of 157,600 shares, vests over a three-year period, with 1/3rd of the total shares subject to the option vesting at each of the 1st, 2nd and 3rd anniversaries of the August 4, 2025 grant date, subject to the Reporting Person's continuous service as of each vesting date.

SEC source: 0001447028-26-000051 · wk-form4_1790209875.xml · nonDerivative · entry 3

Sawhney Roger · CIK 0001858748 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,825

F1 · kind: The Reporting Person exercised options on September 18, 2026. The Issuer withheld an aggregate of 100,508 shares otherwise issuable upon the exercises to satisfy the aggregate exercise prices.

SEC source: 0001447028-26-000051 · wk-form4_1790209875.xml · nonDerivative · entry 2

Sawhney Roger · CIK 0001858748 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 131,333

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001447028-26-000051 · wk-form4_1790209875.xml · nonDerivative · entry 1

Sawhney Roger · CIK 0001858748 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,533

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001447028-26-000050 · wk-form4_1790209858.xml · derivative · entry 5

Beardsley Robert A · CIK 0001310845 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 78,800 shares

Expires 2036-06-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option, representing a right to purchase a total of 78,800 shares, was fully vested and exercisable as of the June 8, 2026 grant date.

SEC source: 0001447028-26-000050 · wk-form4_1790209858.xml · derivative · entry 4

Beardsley Robert A · CIK 0001310845 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,067

Underlying: Common Shares · 52,533 shares

Expires 2035-03-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option, representing a right to purchase a total of 157,600 shares, vests over a three-year period, with 1/3rd of the total shares subject to the option vesting at each of the 1st, 2nd and 3rd anniversaries of the March 18, 2025 grant date, subject to the Reporting Person's continuous service as of each vesting date.

SEC source: 0001447028-26-000050 · wk-form4_1790209858.xml · nonDerivative · entry 3

Beardsley Robert A · CIK 0001310845 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,276

F1 · kind: The Reporting Person exercised options on September 18, 2026. The Issuer withheld an aggregate of 99,057 shares otherwise issuable upon the exercises to satisfy the aggregate exercise prices.

SEC source: 0001447028-26-000050 · wk-form4_1790209858.xml · nonDerivative · entry 2

Beardsley Robert A · CIK 0001310845 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 131,333

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001447028-26-000050 · wk-form4_1790209858.xml · nonDerivative · entry 1

Beardsley Robert A · CIK 0001310845 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,533

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001447028-26-000040 · wk-form4_1781121928.xml · derivative · entry 1

Sawhney Roger · CIK 0001858748 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,800

Underlying: Common Shares · 78,800 shares

Expires 2036-06-08

F1 · derivative.exercise_price: Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant.

F2 · derivative.exercise_date: The option is fully vested and exercisable as of the date of the grant.

SEC source: 0001447028-26-000039 · wk-form4_1781121921.xml · derivative · entry 1

Beardsley Robert A · CIK 0001310845 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,800

Underlying: Common Shares · 78,800 shares

Expires 2036-06-08

F1 · derivative.exercise_price: Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant.

F2 · derivative.exercise_date: The option is fully vested and exercisable as of the date of the grant.

SEC source: 0001447028-26-000009 · wk-form4_1770081692.xml · derivative · entry 2

Nguyen Tuan · CIK 0002063445 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 188,400

Underlying: Common Shares · 188,400 shares

Expires 2036-02-02

F2 · derivative.exercise_price: Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant.

F3 · derivative.exercise_date: This option vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date, subject to the Reporting Person's continuous service as of each vesting date.

SEC source: 0001447028-26-000009 · wk-form4_1770081692.xml · nonDerivative · entry 1

Nguyen Tuan · CIK 0002063445 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,500

F1 · shares: Represents the grant of restricted stock units ("RSUs"), which represent a contingent right to receive one common share for each RSU. The RSUs vest in three equal annual installments beginning one year from the grant date, subject to the Reporting Person's continuous service as of each vesting date. Unless otherwise provided, on each vesting date, common shares will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction.

SEC source: 0001447028-26-000008 · wk-form4_1770081671.xml · derivative · entry 2

Androski Lindsay · CIK 0001936604 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,700

Underlying: Common Shares · 71,700 shares

Expires 2036-02-02

F2 · derivative.exercise_price: Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant.

F3 · derivative.exercise_date: This option vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date, subject to the Reporting Person's continuous service as of each vesting date.

SEC source: 0001447028-26-000008 · wk-form4_1770081671.xml · nonDerivative · entry 1

Androski Lindsay · CIK 0001936604 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,000

F1 · shares: Represents the grant of restricted stock units ("RSUs"), which represent a contingent right to receive one common share for each RSU. The RSUs vest in three equal annual installments beginning one year from the grant date, subject to the Reporting Person's continuous service as of each vesting date. Unless otherwise provided, on each vesting date, common shares will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction.

SEC source: 0001447028-25-000120 · wk-form4_1754510902.xml · derivative · entry 1

Sawhney Roger · CIK 0001858748 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 157,600

Underlying: Common Shares · 157,600 shares

Expires 2035-08-04

F1 · derivative.exercise_price: Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant.

F2 · derivative.exercise_date: This option vests over a three-year period, with 1/3rd of the total shares subject to the option vesting at each of the 1st, 2nd, and 3rd anniversaries of the grant date, subject to the Reporting Person's continuous service as of each vesting date.

SEC source: 0001447028-25-000088 · wk-form4_1743452635.xml · derivative · entry 1

Nguyen Tuan · CIK 0002063445 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 750,000

Underlying: Common Shares · 750,000 shares

Expires 2035-03-31

F1 · derivative.exercise_price: Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant.

F2 · derivative.exercise_date: This option vests over a four-year period, with 25% of the total shares subject to the option vesting on the 1st anniversary of the grant date and the remaining 75% vesting over the subsequent three-year period in substantially equal monthly installments at a rate of 1/48th of the total shares subject to the option each month, subject to the Reporting Person's continuous service as of each vesting date.

SEC source: 0001447028-25-000090 · wk-form4a_1743544061.xml · derivative · entry 1

Nguyen Tuan · CIK 0002063445 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 750,000

Underlying: Common Shares · 750,000 shares

Expires 2035-03-31

F1 · derivative.exercise_price: Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant.

F2 · derivative.exercise_date: This option vests over a four-year period, with 25% of the total shares subject to the option vesting on the 1st anniversary of the grant date and the remaining 75% vesting over the subsequent three-year period in substantially equal monthly installments at a rate of 1/48th of the total shares subject to the option each month, subject to the Reporting Person's continuous service as of each vesting date.

SEC source: 0001447028-25-000077 · wk-form4_1742501645.xml · derivative · entry 1

Hasija Anuj · CIK 0002058570 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 157,600

Underlying: Common Shares · 157,600 shares

Expires 2035-03-18

F1 · derivative.exercise_price: Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant.

F2 · derivative.exercise_date: This option vests over a three-year period, with 1/3rd of the total shares subject to the option vesting at each of the 1st, 2nd, and 3rd anniversaries of the grant date, subject to the Reporting Person's continuous service as of each vesting date.

SEC source: 0001447028-25-000072 · wk-form4_1742501306.xml · derivative · entry 1

Androski Lindsay · CIK 0001936604 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 310,422

Underlying: Common Shares · 310,422 shares

Expires 2035-03-18

F1 · derivative.exercise_price: Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant.

F2 · derivative.exercise_date: This option vests over a four-year period, with 25% of the total shares subject to the option vesting on the 1st anniversary of the grant date and the remaining 75% vesting over the subsequent three-year period in substantially equal monthly installments at a rate of 1/48th of the total shares subject to the option each month, subject to the Reporting Person's continuous service as of each vesting date.

SEC source: 0001447028-25-000075 · wk-form4_1742501408.xml · derivative · entry 1

Beardsley Robert A · CIK 0001310845 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 157,600

Underlying: Common Shares · 157,600 shares

Expires 2035-03-18

F1 · derivative.exercise_price: Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant.

F2 · derivative.exercise_date: This option vests over a three-year period, with 1/3rd of the total shares subject to the option vesting at each of the 1st, 2nd, and 3rd anniversaries of the grant date, subject to the Reporting Person's continuous service as of each vesting date.

SEC source: 0001447028-25-000049 · wk-form4_1740007514.xml · derivative · entry 2

Sims Karen · CIK 0001984652 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,300

Underlying: Common Shares · 200,300 shares

Expires 2035-02-14

F2 · derivative.exercise_price: Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant.

F3 · derivative.exercise_date: This option vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date, subject to the Reporting Person's continuous service as of each vesting date.

SEC source: 0001447028-25-000049 · wk-form4_1740007514.xml · nonDerivative · entry 1

Sims Karen · CIK 0001984652 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 155,494

F1 · shares: Represents the grant of restricted stock units ("RSUs"), which represent a contingent right to receive one common share for each RSU. The RSUs vest in three equal annual installments beginning one year from the grant date, subject to the Reporting Person's continuous service as of each vesting date. Unless otherwise provided, on each vesting date, common shares will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction.

SEC source: 0001447028-25-000052 · wk-form4_1740007544.xml · derivative · entry 2

Naftzger J. Christopher · CIK 0001496194 · General Counsel and CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 220,300

Underlying: Common Shares · 220,300 shares

Expires 2035-02-14

F2 · derivative.exercise_price: Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant.

F3 · derivative.exercise_date: This option vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date, subject to the Reporting Person's continuous service as of each vesting date.

SEC source: 0001447028-25-000052 · wk-form4_1740007544.xml · nonDerivative · entry 1

Naftzger J. Christopher · CIK 0001496194 · General Counsel and CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 140,544

F1 · shares: Represents the grant of restricted stock units ("RSUs"), which represent a contingent right to receive one common share for each RSU. The RSUs vest in three equal annual installments beginning one year from the grant date, subject to the Reporting Person's continuous service as of each vesting date. Unless otherwise provided, on each vesting date, common shares will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction.

SEC source: 0001447028-25-000051 · wk-form4_1740007534.xml · derivative · entry 2

McElhaugh Michael J. · CIK 0001635326 · Director · Interim President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 718,800

Underlying: Common Shares · 718,800 shares

Expires 2035-02-14

F2 · derivative.exercise_price: Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant.

F3 · derivative.exercise_date: This option vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date, subject to the Reporting Person's continuous service as of each vesting date.

SEC source: 0001447028-25-000051 · wk-form4_1740007534.xml · nonDerivative · entry 1

McElhaugh Michael J. · CIK 0001635326 · Director · Interim President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,658,003

F1 · shares: Represents the grant of restricted stock units ("RSUs"), which represent a contingent right to receive one common share for each RSU. The RSUs vest in three equal annual installments beginning one year from the grant date, subject to the Reporting Person's continuous service as of each vesting date. Unless otherwise provided, on each vesting date, common shares will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction.

SEC source: 0001447028-25-000050 · wk-form4_1740007524.xml · derivative · entry 2

HASTINGS DAVID C · CIK 0001237401 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 365,800

Underlying: Common Shares · 365,800 shares

Expires 2035-02-14

F2 · derivative.exercise_price: Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant.

F3 · derivative.exercise_date: This option vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date, subject to the Reporting Person's continuous service as of each vesting date.

SEC source: 0001447028-25-000050 · wk-form4_1740007524.xml · nonDerivative · entry 1

HASTINGS DAVID C · CIK 0001237401 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 249,824

F1 · shares: Represents the grant of restricted stock units ("RSUs"), which represent a contingent right to receive one common share for each RSU. The RSUs vest in three equal annual installments beginning one year from the grant date, subject to the Reporting Person's continuous service as of each vesting date. Unless otherwise provided, on each vesting date, common shares will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction.

SEC source: 0001447028-25-000039 · wk-form4_1738789353.xml · nonDerivative · entry 1

Sims Karen · CIK 0001984652 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 106,194

F1 · kind: Represents the non-discretionary sale of common shares pursuant to the Reporting Person's 10b5-1 Plan, adopted on March 9, 2023, to satisfy the Reporting Person's tax obligations with respect to the vesting of previous grants of restricted stock units.

SEC source: 0001447028-25-000037 · wk-form4_1738789328.xml · nonDerivative · entry 1

Naftzger J. Christopher · CIK 0001496194 · General Counsel and CCO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 86,244

F1 · kind: Represents the non-discretionary sale of common shares pursuant to the Reporting Person's 10b5-1 Plan, adopted on July 11, 2023, to satisfy the Reporting Person's tax obligations with respect to the vesting of previous grants of restricted stock units.

F2 · balance_after: Includes 1,214 and 1,263 shares acquired under the Arbutus Biopharma Corporation 2020 Employee Stock Purchase Plan on February 29, 2024 and August 30, 2024, respectively.

SEC source: 0001447028-25-000040 · wk-form4_1738789366.xml · nonDerivative · entry 1

HASTINGS DAVID C · CIK 0001237401 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 159,724

F1 · kind: Represents the non-discretionary sale of common shares pursuant to the Reporting Person's 10b5-1 Plan, adopted on March 6, 2023, to satisfy the Reporting Person's tax obligations with respect to the vesting of previous grants of restricted stock units.

SEC source: 0001447028-25-000038 · wk-form4_1738789341.xml · nonDerivative · entry 1

McElhaugh Michael J. · CIK 0001635326 · Director · Interim President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,481,003

F1 · kind: Represents the non-discretionary sale of common shares pursuant to the Reporting Person's 10b5-1 Plan, adopted on March 3, 2023, to satisfy the Reporting Person's tax obligations with respect to the vesting of previous grants of restricted stock units.

SEC source: 0001447028-24-000078 · wk-form4_1723838854.xml · derivative · entry 3

MANCHESTER KEITH S · CIK 0001244828 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 54,915 shares

Expires 2024-11-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Cashless exercise and hold transaction in director stock options due to expire on November 13, 2024, ten years after such options were granted, including the sale of 8,846 of the underlying shares to pay the exercise price. None of the net 46,069 shares were sold.

F2 · derivative.exercise_date: This is a director stock option grant that is fully vested.